THE PHAGE
THE PHAGE develops personalized preventive-health services and AI models based on continuous glucose data.
¥570MSeries A first close
ParticipantGV
Genesia Ventures
Activity from announced rounds
Activity in this selectionAI · Series A
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $3.6M 1 disclosed · full round size, not this investor’s share